Treeline to go public via reverse merger with Standard BioTools

Treeline Biosciences co-founders Josh Bilenker (left) and Jeff Engelman June 8, 2026 11:16 AM EDTUpdated 01:30 PM DealsR&D Tree­line to go pub­lic via re­verse merg­er with Stan­dard BioTools Ayisha Sharma News Reporter Tree­line Bio­sciences has shared plans to de­but on pub­lic mar­kets through a re­verse merg­er with Stan­dard BioTools in a move that should give the com­pa­ny … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER